Skip to main content
Clinical Trials/NCT00356629
NCT00356629
Terminated
Not Applicable

Development of a Noninvasive Method of Evaluation of the Pulmonary Inflammation in the Condensates of Exhaled Air

University Hospital, Tours1 site in 1 country100 target enrollmentJuly 2006

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Bronchopulmonary Ignition
Sponsor
University Hospital, Tours
Enrollment
100
Locations
1
Status
Terminated
Last Updated
17 years ago

Overview

Brief Summary

The aim of the study is identify biological parameters reflecting proteolytic activity in the exhaled condenstaes which might be useful to follow up pulmonary inflammation in various conditions including cystic fibrosis, COPD, asthma, tobacco exposure. Three proteases will be analyzed, i.e. elastase, proteinase 3 and cathepsin G. Results in the condensates will be compared to those obtained in sputum.

Detailed Description

5 groups of 20 individuals each: group 1 CF, group 2 COPD, group 3 asthma, group 4 tobacco exposure, group 5 control subjects. Collection of exhaled condensates in all subjects and of sputum in subjects belonging to groups 1 and 2. Clinical examination and PFTs in all patients.

Registry
clinicaltrials.gov
Start Date
July 2006
End Date
July 2008
Last Updated
17 years ago
Study Type
Observational
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • acute exacerbation of the disease during the last 2 weeks
  • IV or oral steroids or antibiotics during the last 2 weeks
  • hospitalization during the last 2 weeks
  • colonization by S aureus methicillin resistant and/or Burkholderia cepacia

Outcomes

Primary Outcomes

Not specified

Study Sites (1)

Loading locations...

Similar Trials